Procurement Summary
Country: Kazakhstan
Summary: Purchase of Reagents for the Allegria Analyzer, Amt: 2091804.00
Deadline: 17 Apr 2026
Posting Date: 14 Apr 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 139500320
Document Ref. No.: 16780640-1
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: KZT 2091804.00
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Lots: Set of reagents Anti-phospholipid screening, IgM for the Allegria analyzer, 24 studies. The Anti-Phospholipid Screen IgM Kit is intended for the quantitative determination of IgM antibodies to phospholipids in human serum or plasma samples using the enzyme immunoassay for the diagnosis of primary and secondary antiphospholipid syndrome based on SMC technology only for use in conjunction with the Alegria analyzer. Antigens: a mixture of highly purified human phospholipids (cardiolipin, phosphatidylserine, phosphatidylinositol, phosphatidylic acid) in each well saturated with highly purified human beta-2-glycoprotein I. Hence, this method specifically detects antibodies to the listed phospholipids or complex negatively charged phospholipid and β2-glycoprotein I. A special technology for applying antigens to cells guarantees the native immunogenic structure of phospholipids after immobilization on the solid phase. Measuring range: 0.5-100 MPL U/ml. Sensitivity: 0.5 MPL E/ml. 24 studies. The remaining shelf life upon delivery is at least 60% of the shelf life indicated on the packaging. | Anti-phospholipid screening reagent kit, IgG for Allegria analyzer, 24 studies. The Anti-Phospholipid Screen IgG kit is designed to for the quantitative determination of IgG antibodies to phospholipids in samples of human serum or blood plasma by enzyme immunoassay for the diagnosis of primary and secondary antiphospholipid syndrome based on...
Documents
Tender Notice